IN2013MU02145A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02145A IN2013MU02145A IN2145MU2013A IN2013MU02145A IN 2013MU02145 A IN2013MU02145 A IN 2013MU02145A IN 2145MU2013 A IN2145MU2013 A IN 2145MU2013A IN 2013MU02145 A IN2013MU02145 A IN 2013MU02145A
- Authority
- IN
- India
- Prior art keywords
- monoclonal antibody
- purification
- provides
- desired monoclonal
- purity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103121726A TWI596107B (zh) | 2013-06-25 | 2014-06-24 | 單株抗體之新穎純化方法 |
ARP140102380A AR096713A1 (es) | 2013-06-25 | 2014-06-24 | Proceso de purificación para anticuerpos monoclonales |
AU2014300486A AU2014300486B2 (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
JP2015563045A JP6039828B2 (ja) | 2013-06-25 | 2014-06-25 | モノクローナル抗体の精製方法 |
KR1020157035759A KR101683415B1 (ko) | 2013-06-25 | 2014-06-25 | 단일클론항체에 대한 정제 방법 |
NZ714079A NZ714079A (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
IN2145MU2013 IN2013MU02145A (zh) | 2013-06-25 | 2014-06-25 | |
US14/895,432 US9708365B2 (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
EP14777867.4A EP3013849B1 (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
BR112015031196A BR112015031196A2 (pt) | 2013-06-25 | 2014-06-25 | “processo de purificação de anticorpo monoclonal” |
SG11201509502XA SG11201509502XA (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
MX2015016586A MX350610B (es) | 2013-06-25 | 2014-06-25 | Proceso para la purificacion de anticuerpos monoclonales. |
EA201592192A EA201592192A1 (ru) | 2013-06-25 | 2014-06-25 | Способ очистки моноклональных антител |
PCT/IN2014/000421 WO2014207763A1 (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
CA2911874A CA2911874A1 (en) | 2013-06-25 | 2014-06-25 | Purification process for monoclonal antibodies |
CN201480031532.XA CN105263947A (zh) | 2013-06-25 | 2014-06-25 | 单克隆抗体的纯化工艺 |
ZA2015/08258A ZA201508258B (en) | 2013-06-25 | 2015-11-09 | Purification process for monoclonal antibodies |
IL242649A IL242649A (en) | 2013-06-25 | 2015-11-18 | Purification process of monoclonal antibody |
HK16105366.7A HK1217344A1 (zh) | 2013-06-25 | 2016-05-11 | 單克隆抗體的純化工序 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2145MU2013 IN2013MU02145A (zh) | 2013-06-25 | 2014-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU02145A true IN2013MU02145A (zh) | 2015-06-05 |
Family
ID=51655799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2145MU2013 IN2013MU02145A (zh) | 2013-06-25 | 2014-06-25 |
Country Status (19)
Country | Link |
---|---|
US (1) | US9708365B2 (zh) |
EP (1) | EP3013849B1 (zh) |
JP (1) | JP6039828B2 (zh) |
KR (1) | KR101683415B1 (zh) |
CN (1) | CN105263947A (zh) |
AR (1) | AR096713A1 (zh) |
AU (1) | AU2014300486B2 (zh) |
BR (1) | BR112015031196A2 (zh) |
CA (1) | CA2911874A1 (zh) |
EA (1) | EA201592192A1 (zh) |
HK (1) | HK1217344A1 (zh) |
IL (1) | IL242649A (zh) |
IN (1) | IN2013MU02145A (zh) |
MX (1) | MX350610B (zh) |
NZ (1) | NZ714079A (zh) |
SG (1) | SG11201509502XA (zh) |
TW (1) | TWI596107B (zh) |
WO (1) | WO2014207763A1 (zh) |
ZA (1) | ZA201508258B (zh) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI398554B (zh) * | 2010-07-29 | 2013-06-11 | Zhen Ding Technology Co Ltd | 電鍍裝置 |
WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
WO2014143205A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
AR096713A1 (es) | 2013-06-25 | 2016-01-27 | Cadila Healthcare Ltd | Proceso de purificación para anticuerpos monoclonales |
EP3052640A2 (en) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US10376582B2 (en) | 2013-10-16 | 2019-08-13 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
EP3247718B1 (en) * | 2015-01-21 | 2021-09-01 | Outlook Therapeutics, Inc. | Modulation of charge variants in a monoclonal antibody composition |
AU2016233557B2 (en) * | 2015-03-13 | 2021-06-24 | Bristol-Myers Squibb Company | Use of alkaline washes during chromatography to remove impurities |
CN107835819A (zh) | 2015-08-21 | 2018-03-23 | 豪夫迈·罗氏有限公司 | 在亲和层析中减少宿主细胞蛋白的方法 |
ES2877532T3 (es) * | 2015-08-21 | 2021-11-17 | Hoffmann La Roche | Procedimiento para la reducción de proteínas de célula huésped en cromatografía de afinidad |
CA3013336A1 (en) | 2016-02-03 | 2017-08-10 | Oncobiologics, Inc. | Buffer formulations for enhanced antibody stability |
EP3500297A1 (en) | 2016-08-16 | 2019-06-26 | Regeneron Pharmaceuticals, Inc. | Methods for quantitating individual antibodies from a mixture |
PL3532838T3 (pl) | 2016-10-25 | 2022-10-03 | Regeneron Pharmaceuticals, Inc. | Metody i systemy analizy danych chromatograficznych |
AU2017347809A1 (en) * | 2016-10-28 | 2019-05-09 | Merck Sharp & Dohme Llc | Purification process for removal of tyrosine sulfation antibody variants; purified compositions |
CR20190291A (es) | 2016-12-23 | 2019-11-05 | Serum Institute Of India Pvt Ltd | Métodos mejorados para estimular la productividad de anticuerpos en el cultivo de células de mamiferos y reducir la agregación durante los procesos de formulación post-tratamiento (downstream) y formulaciones de anticuerpos estables obtenidas a partir de los mismos |
TWI679052B (zh) * | 2017-05-16 | 2019-12-11 | 南韓商Cj醫藥健康股份有限公司 | 使用親和力層析術純化抗體或其抗體片段的方法 |
EP3431168A1 (en) * | 2017-07-19 | 2019-01-23 | Bayer Aktiengesellschaft | Élimination de médicament non lié après couplage conjugué anticorps-médicament |
CN108101987A (zh) * | 2017-11-17 | 2018-06-01 | 安徽未名生物医药有限公司 | 一种重组抗TNF-α全人源单克隆抗体的纯化方法 |
CN110128538B (zh) * | 2018-02-09 | 2022-08-26 | 鲁南制药集团股份有限公司 | 一种纯化抗cd20人鼠嵌合单克隆抗体的方法 |
WO2019183334A1 (en) | 2018-03-21 | 2019-09-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbents, devices and methods |
TW202005694A (zh) | 2018-07-02 | 2020-02-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
WO2020016417A1 (en) * | 2018-07-19 | 2020-01-23 | Ichnos Sciences S.A. | Liquid antibody formulation |
KR102337683B1 (ko) * | 2018-09-21 | 2021-12-13 | 주식회사 녹십자 | 고효율 항-tfpi 항체 조성물 |
CN111072773A (zh) * | 2018-10-19 | 2020-04-28 | 菲鹏生物股份有限公司 | 抗体的纯化方法、抗体和应用 |
WO2020084503A1 (en) | 2018-10-26 | 2020-04-30 | Cadila Healthcare Limited | A composition comprising antibody with reduced level of basic variants thereof |
EP3643322A1 (en) * | 2018-10-26 | 2020-04-29 | Mabion SA | Low aggregate anti cd20 ligand formulation |
CN109320611B (zh) * | 2018-10-31 | 2022-06-03 | 鼎康(武汉)生物医药有限公司 | 一种人鼠嵌合单克隆抗体生物类似药的纯化方法 |
CN111153993A (zh) * | 2018-11-07 | 2020-05-15 | 正大天晴药业集团南京顺欣制药有限公司 | 抗TNF-α单克隆抗体的制备方法 |
CN109336969B (zh) * | 2018-11-09 | 2021-02-12 | 杭州奕安济世生物药业有限公司 | 一种抗体的纯化方法 |
IL293047A (en) | 2019-11-22 | 2022-07-01 | Morphosys Ag | A method for increasing antibody yield during ion exchange chromatography |
WO2021139720A1 (zh) * | 2020-01-08 | 2021-07-15 | 信达生物制药(苏州)有限公司 | 阿达木单抗纯化方法及其稳定组合物 |
KR102154952B1 (ko) * | 2020-02-21 | 2020-09-10 | 프레스티지바이오로직스 주식회사 | 아달리무맙의 Non-Protein A 정제방법 |
WO2022245306A1 (en) * | 2021-05-20 | 2022-11-24 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Protein purification by affinity chromatography |
CN114133446A (zh) * | 2021-12-31 | 2022-03-04 | 方坦思(上海)生物医药有限公司 | 单克隆抗体的纯化方法 |
CN115491328A (zh) * | 2022-08-31 | 2022-12-20 | 深圳市卫光生物制品股份有限公司 | 一种大肠杆菌表达蛋白及其表达纯化方法 |
EP4335869A1 (en) | 2022-09-07 | 2024-03-13 | Bio T Biyoteknoloji Cozumleri Ve Uretim Anonim | Resin and chromatography column that purifies antibodies with protease resistant small peptides |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
SI1308456T1 (sl) | 1998-05-06 | 2008-02-29 | Genentech Inc | Ciscenje protiteles z ionsko izmenjevalno kromatografijo |
DE69936946T2 (de) | 1998-05-06 | 2008-05-15 | Genentech, Inc., South San Francisco | Reinigung von Antikörpern durch Ionenaustauschchromatographie |
CA2333747C (en) * | 1998-06-01 | 2008-02-19 | Genentech, Inc. | Separation of protein monomers by use of ion-exchange chromatography |
JPWO2004087761A1 (ja) | 2003-03-31 | 2006-07-27 | 麒麟麦酒株式会社 | ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製 |
US7700097B2 (en) | 2003-06-27 | 2010-04-20 | Biogen Idec Ma Inc. | Purification and preferential synthesis of binding molecules |
SE0400501D0 (sv) | 2004-02-27 | 2004-02-27 | Amersham Biosciences Ab | Antibody purification |
MX2007011129A (es) | 2005-03-11 | 2007-11-06 | Wyeth Corp | Un metodo de cromatografia de particion debil. |
ES2405079T3 (es) | 2005-06-17 | 2013-05-30 | Wyeth Llc | Métodos para purificar anticuerpos de la región Fc |
US8263750B2 (en) | 2006-03-16 | 2012-09-11 | Amgen Inc. | Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step |
TWI392684B (zh) | 2006-04-05 | 2013-04-11 | Abbott Biotech Ltd | 抗體之純化 |
WO2008031020A2 (en) | 2006-09-08 | 2008-03-13 | Wyeth | Arginine wash in protein purification using affinity chromatography |
EP2212432A4 (en) | 2007-10-22 | 2011-10-19 | Schering Corp | COMPLETELY HUMAN ANTI-VEGF ANTIBODIES AND USE PROCEDURES |
US20100069617A1 (en) | 2008-09-12 | 2010-03-18 | Ge Healthcare Bio-Sciences Ab | Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions |
WO2010030222A1 (en) | 2008-09-12 | 2010-03-18 | Ge Healthcare Bio-Sciences Ab | Enhanced protein aggregate removal with multimodal anion exchangers in the presence of protein-excluded zwitterions |
SG10201702922VA (en) * | 2008-10-20 | 2017-06-29 | Abbvie Inc | Isolation and purification of antibodies using protein a affinity chromatography |
CN104744560A (zh) | 2009-10-20 | 2015-07-01 | Abbvie公司 | 使用蛋白a亲和色谱法分离和纯化抗-il-13抗体 |
US20130178608A1 (en) * | 2009-12-29 | 2013-07-11 | Samir Kulkarni | Protein purification by ion exchange |
US9284347B2 (en) | 2010-01-22 | 2016-03-15 | Boehringer Ingelheim International Gmbh | Chromatographic method for purifying FC-containing proteins |
CN102179237A (zh) * | 2010-04-26 | 2011-09-14 | 无锡加莱克色谱科技有限公司 | 一种用于分离、提纯单克隆抗体和抗体球蛋白的亲和色谱填料及其制备方法 |
WO2012051147A1 (en) | 2010-10-11 | 2012-04-19 | Abbott Laboratories | Processes for purification of proteins |
KR102027596B1 (ko) | 2010-12-06 | 2019-10-01 | 타폰 바이오시스템즈, 인코포레이티드 | 생물학적 산물을 위한 연속 처리 방법 |
US20120238730A1 (en) | 2011-03-15 | 2012-09-20 | Abbott Laboratories | Integrated approach to the isolation and purification of antibodies |
EP2723759A4 (en) * | 2011-06-24 | 2015-01-28 | Reddys Lab Ltd Dr | PURIFICATION OF CHIMERIC PROTEIN |
WO2013066707A1 (en) * | 2011-10-31 | 2013-05-10 | Merck Sharp & Dohme Corp. | Chromatography process for resolving heterogeneous antibody aggregates |
WO2013075740A1 (en) | 2011-11-23 | 2013-05-30 | Sanofi | Antibody purification method |
US20160024144A1 (en) * | 2013-03-14 | 2016-01-28 | Amgen Inc. | Removal of leaked affinity purification ligand |
EP2997041A4 (en) | 2013-05-13 | 2017-02-15 | Medlmmune, LLC | Separation of recombinant polyclonal antibody multimers with minimal separation of monomers |
AR096713A1 (es) | 2013-06-25 | 2016-01-27 | Cadila Healthcare Ltd | Proceso de purificación para anticuerpos monoclonales |
-
2014
- 2014-06-24 AR ARP140102380A patent/AR096713A1/es unknown
- 2014-06-24 TW TW103121726A patent/TWI596107B/zh not_active IP Right Cessation
- 2014-06-25 US US14/895,432 patent/US9708365B2/en active Active
- 2014-06-25 NZ NZ714079A patent/NZ714079A/en not_active IP Right Cessation
- 2014-06-25 BR BR112015031196A patent/BR112015031196A2/pt not_active IP Right Cessation
- 2014-06-25 SG SG11201509502XA patent/SG11201509502XA/en unknown
- 2014-06-25 AU AU2014300486A patent/AU2014300486B2/en not_active Ceased
- 2014-06-25 MX MX2015016586A patent/MX350610B/es active IP Right Grant
- 2014-06-25 WO PCT/IN2014/000421 patent/WO2014207763A1/en active Application Filing
- 2014-06-25 EP EP14777867.4A patent/EP3013849B1/en not_active Revoked
- 2014-06-25 EA EA201592192A patent/EA201592192A1/ru unknown
- 2014-06-25 JP JP2015563045A patent/JP6039828B2/ja active Active
- 2014-06-25 CN CN201480031532.XA patent/CN105263947A/zh active Pending
- 2014-06-25 IN IN2145MU2013 patent/IN2013MU02145A/en unknown
- 2014-06-25 KR KR1020157035759A patent/KR101683415B1/ko active IP Right Grant
- 2014-06-25 CA CA2911874A patent/CA2911874A1/en not_active Abandoned
-
2015
- 2015-11-09 ZA ZA2015/08258A patent/ZA201508258B/en unknown
- 2015-11-18 IL IL242649A patent/IL242649A/en not_active IP Right Cessation
-
2016
- 2016-05-11 HK HK16105366.7A patent/HK1217344A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NZ714079A (en) | 2017-05-26 |
US9708365B2 (en) | 2017-07-18 |
EA201592192A1 (ru) | 2016-07-29 |
KR101683415B1 (ko) | 2016-12-06 |
IL242649A (en) | 2016-03-31 |
CN105263947A (zh) | 2016-01-20 |
JP2016525500A (ja) | 2016-08-25 |
HK1217344A1 (zh) | 2017-01-06 |
CA2911874A1 (en) | 2014-12-31 |
WO2014207763A1 (en) | 2014-12-31 |
KR20160003311A (ko) | 2016-01-08 |
EP3013849B1 (en) | 2017-09-13 |
US20160115195A1 (en) | 2016-04-28 |
EP3013849A1 (en) | 2016-05-04 |
BR112015031196A2 (pt) | 2017-07-25 |
AU2014300486B2 (en) | 2016-06-30 |
ZA201508258B (en) | 2017-03-29 |
JP6039828B2 (ja) | 2016-12-07 |
MX2015016586A (es) | 2016-03-16 |
MX350610B (es) | 2017-09-11 |
TWI596107B (zh) | 2017-08-21 |
AU2014300486A1 (en) | 2015-11-26 |
SG11201509502XA (en) | 2015-12-30 |
AR096713A1 (es) | 2016-01-27 |
TW201512217A (zh) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MU02145A (zh) | ||
PH12018500707A1 (en) | Anti-human cd19 antibodies with high affinity | |
MX368177B (es) | Proceso continuo de múltiples etapas para purificar anticuerpos. | |
MX2018006973A (es) | Anticuerpos anti-cd73 humanizados. | |
JO3772B1 (ar) | صيغة جسم مضاد لـ cgrp | |
MX364908B (es) | Purificación de proteínas usando amortiguador bis-tris. | |
WO2019083318A3 (ko) | 개선된 면역글로불린의 정제방법 | |
MX2023008870A (es) | Composiciones y metodos para reducir la carga biologica en cromatografia. | |
PH12019502298A1 (en) | Monoclonal antibody to pd-l1 | |
EP3280444A4 (en) | METHOD FOR CLEANING HETERODIMEROUS MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY TYPES | |
WO2018162557A3 (en) | Method for purifying proteins using silicate | |
MX2016013416A (es) | Nuevo proceso de purificacion de gonadotropina. | |
MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
EA201400273A1 (ru) | Способ снижения тромбоэмболического потенциала композиции, содержащей полученный из плазмы иммуноглобулин | |
SG10201806643WA (en) | Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins | |
MX2016000181A (es) | Explicacion de la optimizacion de entrada de la cromatografia de intercambio ionico. | |
EP3575279A4 (en) | PROCESS FOR PRODUCING HIGH CONCENTRATION ALCOHOL | |
MX2019004182A (es) | Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al. | |
SG11201802997WA (en) | Affinity chromatography carrier and method for purifying biological substance | |
EP3560956A3 (en) | Methods of treating inflammatory diseases | |
MX369054B (es) | Detección de moléculas de ácido nucleico. | |
MX2015013182A (es) | Purificacion analitica basada en la afinidad de compuestos bioterapeuticos para el control de bioprocesos. | |
MX2019011343A (es) | Un procedimiento para la purificacion de fragmentos de anticuerpos recombinantes. | |
MY197993A (en) | Method for protein purification | |
EP4239329A3 (en) | Method and apparatus |